PRKAA2 and obesity due to melanocortin 4 receptor deficiency: Importantly, the beneficial effects of RJ on adiposity markers, insulin resistance, and adipogenic and lipolytic markers were completely negated by AMPK inhibition, emphasizing AMPK’s pivotal role in mediating RJ’s anti-obesity, anti-adipogenic, and lipolytic effects.